Literature DB >> 11413119

High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.

J H Henriksen1, S Møller, S Schifter, J Abrahamsen, U Becker.   

Abstract

BACKGROUND AND AIMS: Static and dynamic functions of the wall of large arteries are largely unknown in cirrhosis in vivo. The present study was undertaken to determine arterial compliance (COMP(art)) in relation to vasodilator and vasoconstrictor systems in patients with cirrhosis. In addition, vasoactivity was manipulated by inhalation of oxygen. STUDY POPULATION AND METHODS: In 20 patients with alcoholic cirrhosis and 12 controls we determined COMP(art) (stroke volume relative to pulse pressure), cardiac output, plasma volume, systemic vascular resistance, central circulation time, plasma catecholamines, renin activity, endothelin-1, and calcitonin gene related peptide (CGRP) at baseline and during oxygen inhalation.
RESULTS: COMP(art) was significantly increased in cirrhotic patients compared with controls (1.32 v 1.06 ml/mm Hg; p< 0.05) and inversely related to plasma adrenaline levels (r=-0.53; p<0.02) but positively related to circulating levels of CGRP (r=0.58; p<0.01). No significant relation was found for plasma noradrenaline, renin activity, or endothelin-1. COMP(art) was positively related to plasma volume (r=0.50; p<0.02) and inversely to systemic vascular resistance (r=-0.69; p<0.001) and central circulation time (r=-0.49; p<0.02). During oxygen inhalation, COMP(art) decreased (-13%; p<0.005) and systemic vascular resistance increased (+10%; p<0.001) towards normal values without significant changes in mean arterial pressure. Plasma adrenaline (-16%; p<0.01) decreased and the relation to COMP(art) disappeared. The relation of COMP(art) to CGRP and circulatory variables remained unchanged.
CONCLUSION: Elevated arterial compliance in cirrhosis is related to low adrenaline, high CGRP, and systemic hyperdynamics but not to indicators of the activated vasoconstrictor systems (noradrenaline, renin, endothelin-1). Thus the altered static and dynamic characteristics of the wall of large arteries are intimately associated with circulatory and vasodilatory derangement in cirrhosis but biomanipulation indicates that the changes are, at least in part, reversible during isobaric conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413119      PMCID: PMC1728353          DOI: 10.1136/gut.49.1.112

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  51 in total

1.  Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis.

Authors:  V Arroyo; P Ginés
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

2.  Calcitonin gene related peptide.

Authors:  D J O'Halloran; S R Bloom
Journal:  BMJ       Date:  1991-03-30

Review 3.  Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.

Authors:  S Møller
Journal:  Dan Med Bull       Date:  1998-02

4.  Vasoactive intestinal peptide and calcitonin gene-related peptide levels and hemodynamics during human liver transplantation.

Authors:  P L McNicol; G Liu; A Shulkes; K J Hardy; R M Jones
Journal:  Transplant Proc       Date:  1993-04       Impact factor: 1.066

Review 5.  Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences.

Authors:  R J Groszmann
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

6.  Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis.

Authors:  R Moreau; H Komeichi; P Kirstetter; M Ohsuga; S Cailmail; D Lebrec
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

Review 7.  Hepatorenal disorders: role of the renin-angiotensin-aldosterone system.

Authors:  M Bernardi; F Trevisani; A Gasbarrini; G Gasbarrini
Journal:  Semin Liver Dis       Date:  1994-02       Impact factor: 6.115

8.  Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.

Authors:  R M Priest; D Hucks; J P Ward
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

9.  Elevated circulating plasma endothelin-1 concentrations in cirrhosis.

Authors:  S Møller; C Emmeluth; J H Henriksen
Journal:  J Hepatol       Date:  1993-09       Impact factor: 25.083

10.  Effects of age and aerobic capacity on arterial stiffness in healthy adults.

Authors:  P V Vaitkevicius; J L Fleg; J H Engel; F C O'Connor; J G Wright; L E Lakatta; F C Yin; E G Lakatta
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

View more
  10 in total

Review 1.  Liver cirrhosis and arterial hypertension.

Authors:  Jens H Henriksen; Soren Moller
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

2.  Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors.

Authors:  L Moezi; S A Gaskari; H Liu; S K Baik; A R Dehpour; S S Lee
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

Review 3.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

4.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

Review 5.  Hypertension and liver disease.

Authors:  Jens H Henriksen; Søren Møller
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

6.  Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats.

Authors:  M Ghasemi; H Sadeghipour; H Shafaroodi; B G Nezami; T Gholipour; A R Hajrasouliha; S Tavakoli; M Nobakht; K P Moore; A R Mani; A R Dehpour
Journal:  Br J Pharmacol       Date:  2007-05-08       Impact factor: 8.739

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

8.  Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.

Authors:  J H Henriksen; S Fuglsang; F Bendtsen; S Møller
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

9.  In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.

Authors:  Chien-Hao Huang; Lung-Sheng Wu; Wen-Juei Jeng; Yu-Fu Cheng; Yu-Shien Ko; I-Shyan Sheen; Chun-Yen Lin
Journal:  PLoS One       Date:  2019-03-19       Impact factor: 3.240

Review 10.  Cirrhotic Cardiomyopathy: The Interplay Between Liver and Cardiac Muscle. How Does the Cardiovascular System React When the Liver is Diseased?

Authors:  Spyros P Dourakis; Eleni Geladari; Charalampia Geladari; Natalia Vallianou
Journal:  Curr Cardiol Rev       Date:  2021
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.